444 related articles for article (PubMed ID: 12746913)
21. Clinical responsiveness of self-report functional assessment measures for children with juvenile idiopathic arthritis undergoing intraarticular corticosteroid injections.
Brown GT; Wright FV; Lang BA; Birdi N; Oen K; Stephens D; McComas J; Feldman BM
Arthritis Rheum; 2005 Dec; 53(6):897-904. PubMed ID: 16342103
[TBL] [Abstract][Full Text] [Related]
22. The early pattern of joint involvement predicts disease progression in children with oligoarticular (pauciarticular) juvenile rheumatoid arthritis.
Al-Matar MJ; Petty RE; Tucker LB; Malleson PN; Schroeder ML; Cabral DA
Arthritis Rheum; 2002 Oct; 46(10):2708-15. PubMed ID: 12384930
[TBL] [Abstract][Full Text] [Related]
23. Macrophage migration inhibitory factor gene polymorphism is associated with sarcoidosis in biopsy proven erythema nodosum.
Amoli MM; Donn RP; Thomson W; Hajeer AH; Garcia-Porrua C; Lueiro M; Ollier WE; Gonzalez-Gay MA
J Rheumatol; 2002 Aug; 29(8):1671-3. PubMed ID: 12180727
[TBL] [Abstract][Full Text] [Related]
24. A polymorphism in the macrophage migration inhibitory factor gene is involved in the genetic predisposition of Crohn's disease and associated with cumulative steroid doses.
Griga T; Wilkens C; Wirkus N; Epplen J; Schmiegel W; Klein W
Hepatogastroenterology; 2007; 54(75):784-6. PubMed ID: 17591062
[TBL] [Abstract][Full Text] [Related]
25. Long-term outcome and prognostic factors in enthesitis-related arthritis: a case-control study.
Flatø B; Hoffmann-Vold AM; Reiff A; Førre Ø; Lien G; Vinje O
Arthritis Rheum; 2006 Nov; 54(11):3573-82. PubMed ID: 17075863
[TBL] [Abstract][Full Text] [Related]
26. Promoter region polymorphism of macrophage migration inhibitory factor is strong risk factor for young onset of extensive alopecia areata.
Shimizu T; Hizawa N; Honda A; Zhao Y; Abe R; Watanabe H; Nishihira J; Nishimura M; Shimizu H
Genes Immun; 2005 Jun; 6(4):285-9. PubMed ID: 15815686
[TBL] [Abstract][Full Text] [Related]
27. Lack of association between juvenile idiopathic arthritis and fas gene polymorphism.
Donn R; Zeggini E; Shelley E; Ollier W; Thomson W;
J Rheumatol; 2002 Jan; 29(1):166-8. PubMed ID: 11824955
[TBL] [Abstract][Full Text] [Related]
28. Interleukin-1 receptor antagonist (anakinra) treatment in patients with systemic-onset juvenile idiopathic arthritis or adult onset Still disease: preliminary experience in France.
Lequerré T; Quartier P; Rosellini D; Alaoui F; De Bandt M; Mejjad O; Kone-Paut I; Michel M; Dernis E; Khellaf M; Limal N; Job-Deslandre C; Fautrel B; Le Loët X; Sibilia J; ;
Ann Rheum Dis; 2008 Mar; 67(3):302-8. PubMed ID: 17947302
[TBL] [Abstract][Full Text] [Related]
29. Prognostic factors in juvenile rheumatoid arthritis: a case-control study revealing early predictors and outcome after 14.9 years.
Flatø B; Lien G; Smerdel A; Vinje O; Dale K; Johnston V; Sørskaar D; Moum T; Ploski R; Førre Ø
J Rheumatol; 2003 Feb; 30(2):386-93. PubMed ID: 12563700
[TBL] [Abstract][Full Text] [Related]
30. Tumor necrosis factor-alpha -308 genotypes influence inflammatory activity and TNF-alpha serum concentrations in children with juvenile idiopathic arthritis.
Mourão AF; Caetano-Lopes J; Costa P; Canhão H; Santos MJ; Pinto P; Brito I; Nicola P; Cavaleiro J; Teles J; Sousa A; Gomes JM; Branco J; da Costa JT; Pedro JG; de Queiroz MV; Fonseca JE
J Rheumatol; 2009 Apr; 36(4):837-42. PubMed ID: 19208590
[TBL] [Abstract][Full Text] [Related]
31. Time to treatment as an important factor for the response to methotrexate in juvenile idiopathic arthritis.
Albers HM; Wessels JA; van der Straaten RJ; Brinkman DM; Suijlekom-Smit LW; Kamphuis SS; Girschick HJ; Wouters C; Schilham MW; le Cessie S; Huizinga TW; Ten Cate R; Guchelaar HJ
Arthritis Rheum; 2009 Jan; 61(1):46-51. PubMed ID: 19116975
[TBL] [Abstract][Full Text] [Related]
32. Macrophage migration inhibitory factor upregulates angiogenic factors and correlates with clinical measures in rheumatoid arthritis.
Kim HR; Park MK; Cho ML; Yoon CH; Lee SH; Park SH; Leng L; Bucala R; Kang I; Choe J; Kim HY
J Rheumatol; 2007 May; 34(5):927-36. PubMed ID: 17407222
[TBL] [Abstract][Full Text] [Related]
33. Development and evaluation of a single value score to assess global range of motion in juvenile idiopathic arthritis.
Epps H; Hurley M; Utley M
Arthritis Rheum; 2002 Aug; 47(4):398-402. PubMed ID: 12209486
[TBL] [Abstract][Full Text] [Related]
34. Course of joint disease in patients with antinuclear antibody-positive juvenile idiopathic arthritis.
Felici E; Novarini C; Magni-Manzoni S; Pistorio A; Magnani A; Bozzola E; Buoncompagni A; Martini A; Ravelli A
J Rheumatol; 2005 Sep; 32(9):1805-10. PubMed ID: 16142881
[TBL] [Abstract][Full Text] [Related]
35. A comparison of response criteria to evaluate therapeutic response in patients with juvenile idiopathic arthritis treated with methotrexate and/or anti-tumor necrosis factor alpha agents.
Lurati A; Pontikaki I; Teruzzi B; Desiati F; Gerloni V; Gattinara M; Cimaz R; Fantini F
Arthritis Rheum; 2006 May; 54(5):1602-7. PubMed ID: 16646003
[TBL] [Abstract][Full Text] [Related]
36. Association of the HLA-G 14-bp insertion/deletion polymorphism with juvenile idiopathic arthritis and rheumatoid arthritis.
Veit TD; Vianna P; Scheibel I; Brenol CV; Brenol JC; Xavier RM; Delgado-Cañedo A; Gutierrez JE; Brandalize AP; Schuler-Faccini L; Chies JA
Tissue Antigens; 2008 May; 71(5):440-6. PubMed ID: 18331529
[TBL] [Abstract][Full Text] [Related]
37. Levels of matrix metalloproteinase (MMP)-1 in paired sera and synovial fluids of juvenile idiopathic arthritis patients: relationship to inflammatory activity, MMP-3 and tissue inhibitor of metalloproteinases-1 in a longitudinal study.
Peake NJ; Khawaja K; Myers A; Jones D; Cawston TE; Rowan AD; Foster HE
Rheumatology (Oxford); 2005 Nov; 44(11):1383-9. PubMed ID: 16049050
[TBL] [Abstract][Full Text] [Related]
38. A functional promoter polymorphism in the macrophage migration inhibitory factor (MIF) gene associated with disease severity in rheumatoid arthritis.
Baugh JA; Chitnis S; Donnelly SC; Monteiro J; Lin X; Plant BJ; Wolfe F; Gregersen PK; Bucala R
Genes Immun; 2002 May; 3(3):170-6. PubMed ID: 12070782
[TBL] [Abstract][Full Text] [Related]
39. Association of MIF promoter polymorphisms with psoriasis in a Han population in northeastern China.
Wu J; Chen F; Zhang X; Li Y; Ma H; Zhou Y; Jin Y; Wang H; Bai J; Zhang G; Fu S
J Dermatol Sci; 2009 Mar; 53(3):212-5. PubMed ID: 19157791
[TBL] [Abstract][Full Text] [Related]
40. Outcome in juvenile rheumatoid arthritis in India.
Aggarwal A; Agarwal V; Danda D; Misra R
Indian Pediatr; 2004 Feb; 41(2):180-4. PubMed ID: 15004305
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
